News Listing

Following £2.3m of seed funding, Nium has relocated its HQ to Milton Park, where it hopes to innovate using nanotechnology to eliminate emissions from ammonia production (one of the planet’s most critical, yet polluting industrial processes).

Nium joins an increasing number of companies at Milton Park who are focused in the green energy sector, including Tokamak Energy, which is advancing ...

CryoLogyx, announces it has raised £500k in seed funding from private UK business angels and the Wider Oxford Technology Angel Network (WOTAN). The funding will be used to support commercialization of pre-plated, assay-ready, cryopreserved cells for drug discovery, diagnostic and cell therapy applications.

Start-ups working in FemTech and women's health are urged to join a new growth programme hosted by Discovery Park, Kent's science park and R&D community. 

The programme offers tailored mentoring and support for start-ups, preparing founders for success in investment pitches. Companies will compete to win a support package worth over £50K, including 1 year of lab or office space at Discovery ...

Exploristics’ cloud-based simulation platform KerusCloud used to enhance study design for Exonate’s upcoming Phase IIb study following successful Phase Ib/IIa study

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively to help bridge the gender discrepancy gap in many areas of research.

Until 1993, most clinical trial participants were men of European descent, leading to a lack of data on the safety and efficacy of treatments for women and diverse populations. Although ...

Sandwich, Kent, UK / 28th February 2024 / Discovery Park, Kent’s thriving life science community, is marking International Women’s Day by supporting women in business and tackling gender bias in healthcare. 

Neobe Therapeutics, a pioneering synthetic biology startup at the forefront of immuno-oncology innovation, is thrilled to announce the successful closure of a $2.34m financing round.

Restore Harrow Green is once again expanding our footprint and opening another new branch, this time in Oxford!